Latest European Union News

Euro Manganese has successfully closed a C$11.2 million financing round, attracting heavyweight investors including the European Bank for Reconstruction and Development and Eric Sprott. The funds will accelerate development of its Chvaletice Manganese Project, a critical European source of battery-grade manganese.

Sprintex has commissioned an upgraded manure processing system with Mest Water, setting the stage for a major trial at Van Drie Group farms that could unlock A$8.4 million in revenue. The company is also expanding its market reach with a new mobile system targeting smaller farms amid tightening EU ammonia regulations.

Euro Manganese is poised to close a C$11.2 million financing round by late May, fueling progress on its strategic Chvaletice manganese project in the Czech Republic. The move underscores the company's role in Europe's battery materials supply chain.

Elementos Limited has locked in a $5 million strategic placement from Australia’s largest tin producer, Metals X, to accelerate development of its key tin projects in Spain and Tasmania.

ITM Isotope Technologies Munich SE and Radiopharm Theranostics have entered a strategic supply agreement for the critical radioisotope Lutetium-177, underpinning Radiopharm’s clinical development of targeted cancer therapies.

The Finnish Government’s proposed amendments to the Mining Act could resolve licensing uncertainties for Latitude 66’s KSB Project, even as key mining rights expire following a court decision.

Euro Manganese has successfully closed an oversubscribed Security Purchase Plan, raising A$1.5 million to advance its Chvaletice Manganese Project in the Czech Republic. The capital injection will support project development, strategic partnerships, and working capital needs.

Euro Manganese Inc. reported a net loss of CAD 9.174 million for the half-year ending March 31, 2025, while making significant progress on its Chvaletice Manganese Project, including securing key permits and strategic status under EU and Czech frameworks. The company’s development hinges on completing a crucial private placement and share purchase plan to sustain operations.

Euro Manganese advances its Chvaletice manganese project with key regulatory approvals, leadership appointments, and a $9.8 million capital raise, while reporting a narrowed Q3 net loss.

Orthocell has secured regulatory approval to sell its nerve repair product Remplir™ in Hong Kong well ahead of schedule, expanding its footprint across key global markets. This milestone complements recent clearances in the US, Canada, and Asia, positioning the company for significant growth in a multi-billion-dollar market.

Euro Manganese has appointed Martina Blahova as its permanent CEO, cementing leadership continuity as the company advances its strategic Chvaletice Manganese Project in Europe.

AVITA Medical reported a robust 67% increase in first quarter 2025 revenue, driven by new product launches and a strategic commercial overhaul, while reaffirming its full-year growth and profitability targets.